| Analysis | Metabolite Name | Measured Value | Units | Group |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.2016 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4283 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4290 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4351 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4663 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4692 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4719 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.4898 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.5066 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.5334 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.5351 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.5598 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.5826 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6076 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6092 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6120 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6268 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6402 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6782 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6848 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.6954 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7073 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7098 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7125 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7316 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7425 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7557 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7613 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7647 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7651 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7660 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7792 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7805 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7846 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7849 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.7880 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8029 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8158 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8183 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8212 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8254 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8455 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8473 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8617 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8674 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8726 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8761 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8775 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8872 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8881 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8943 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.8947 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9008 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9296 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9318 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9394 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9422 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9519 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9579 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9605 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9810 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9852 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9879 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9883 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 0.9953 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0000 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0073 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0135 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0283 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0335 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0350 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0412 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0542 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0568 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0569 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0654 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0690 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0707 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0796 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0880 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.0934 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1004 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1064 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1191 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1410 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1423 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1518 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1827 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1838 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1904 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1913 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.1978 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2104 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2124 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2478 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2619 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2863 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2904 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.2923 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3058 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3078 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3378 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3404 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3888 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.3993 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4127 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4176 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4510 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4516 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4872 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.4874 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.5250 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.5282 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.5934 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.5989 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.6182 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.6239 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.6467 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.6527 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.7971 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.9231 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 1.9561 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.0556 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.0699 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.0868 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.1254 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.1604 | Peak area | Lean |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.2509 | Peak area | Obese neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.5167 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.5509 | Peak area | Obese non neuropathy |
| Reversed phase POSITIVE ION MODE | arachidonate (20:4n6) | 2.8053 | Peak area | Obese non neuropathy |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|